Predictors of survival in idiopathic interstitial pneumonia

R. Carbone, M. Grosso, F. Montanaro, A. Monselise, D. Cantalupi, G. Bottino, E. Balleari, R. Ghio (Aosta, Genoa, Italy; Tel Aviv, Israel)

Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Carbone, M. Grosso, F. Montanaro, A. Monselise, D. Cantalupi, G. Bottino, E. Balleari, R. Ghio (Aosta, Genoa, Italy; Tel Aviv, Israel). Predictors of survival in idiopathic interstitial pneumonia. Eur Respir J 2007; 30: Suppl. 51, 815

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
Source: Eur Respir J 2002; 19: 1114-1118
Year: 2002



Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018




Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
Source: Eur Respir J 2012; 40: 101-109
Year: 2012



Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia
Source: International Congress 2017 – Lung function testing
Year: 2017

Quantifying risk of mortality in idiopathic interstitial pneumonia (IIP)
Source: Eur Respir J 2001; 18: Suppl. 33, 149s
Year: 2001

Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia.
Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias
Year: 2018


High short-term mortality following lung biopsy for usual interstitial pneumonia
Source: Eur Respir J 2001; 17: 175-179
Year: 2001



Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002



Smoking-related idiopathic interstitial pneumonia
Source: Eur Respir J 2014; 44: 594-602
Year: 2014



Prognostic factors analysis of patients with acute exacerbation of idiopathic interstitial pneumonias treated by polymyxin B hemoperfusion
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013


The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008



Causes of chronic cough in patients with interstitial pneumonia
Source: Annual Congress 2008 - Lung function, airways and cough
Year: 2008

Non-IPF idiopathic interstitial pneumonias
Source: School Course 2014 - Interstitial lung diseases
Year: 2014

Biopsy documented idiopathic interstitial pneumonias - Analysis of diagnostic yield, survival and mortality over 9 years
Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions
Year: 2013


Survival predictors in a cohort of patients with idiopathic pulmonary fibrosis biopsy-proven
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012


Late-onset “acute fibrinous and organising pneumonia” impairs long-term lung allograft function and survival
Source: Eur Respir J, 56 (3) 1902292; 10.1183/13993003.02292-2019
Year: 2020



Severity before or at the onset of acute exacerbation (AE) can predict the long-term and short-term survival of AE in idiopathic interstitial pneumonias (IIPs)?
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia
Source: Eur Respir J, 52 (1) 1800545; 10.1183/13993003.00545-2018
Year: 2018



Cyclosporine A in the treatment of idiopathic pulmonary fibrosis/usual interstitial pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 62s
Year: 2002

Recent improvement of survival of acute exacerbation in idiopathic interstitial pneumonias: 10 years experience
Source: International Congress 2014 – ILDs 2
Year: 2014